D
Celldex Therapeutics, Inc. CLDX
$21.75 -$0.18-0.82% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -57.92% -63.97% -8.74% -10.09% -17.51%
Total Depreciation and Amortization 9.54% 11.87% 7.91% 2.48% 5.42%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 158.79% 80.99% 27.58% -3.69% -28.52%
Change in Net Operating Assets 49.65% 32.04% 48.08% -248.34% 286.99%
Cash from Operations -50.05% -33.80% 0.18% -191.35% -7.84%
Capital Expenditure -165.69% 22.97% -13.51% -247.13% 33.17%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 208.89% 113.72% 114.55% 309.24% -3,051.02%
Cash from Investing 206.69% 113.63% 114.05% 310.08% -4,114.00%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -98.30% -99.95% -99.82% 382.10% 2,690.98%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -98.30% -99.95% -99.82% 382.10% 2,690.98%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 108.17% -113.98% -158.79% 10.58% -179.31%